Edwin Posadas, Md
Clinical trials sponsored by Edwin Posadas, Md, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo aims to fight Drug-Resistant prostate cancer Results expected Jan 2027 (estimated)
-
Can epigenetic drugs prime prostate tumors for immune attack before surgery?
Disease control Recruiting nowThis early-phase trial is testing whether giving epigenetic therapy before prostate removal can make the cancer more visible to the immune system. About 20 men with high-risk prostate cancer will receive the drugs before their scheduled prostatectomy. The main goals are to check …
Early phase 1 • Sponsor: Edwin Posadas, MD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo aims to fight Drug-Resistant prostate cancer
Disease control Recruiting nowThis phase 2 trial is testing whether adding carotuximab to the standard drug apalutamide can help men with metastatic castration-resistant prostate cancer that has stopped responding to other treatments. About 100 participants will receive either apalutamide alone or the combina…
Phase 2 • Sponsor: Edwin Posadas, MD • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC